Indicator Capital

Indicator Capital is a Sao Paulo-based fund specializing in industrial IoT and AI-driven hardware-software solutions, with crossover applications in industrial and health sectors. Check sizes of $1M to $5M place the firm in the institutional seed and small Series A range. Healthcare exposure includes AI/ML in healthcare, health-IT software, and medical devices/medtech, with the firm’s broader industrial IoT thesis as the unifying lens.

The firm’s natural fit is with founders building hardware-software products at the edge of industrial and health applications, including connected medical devices, AI-enabled diagnostic hardware, IoT-enabled health monitoring infrastructure, and clinical workflow tools that integrate with hospital operational systems. The right founder profile is a technical team with hardware-software expertise and a credible industrial or health enterprise wedge. Founders building pure software, DTC consumer health, or biotech are not the natural target.

Geographically, Brazil has a real industrial base (Sao Paulo and surrounding states host significant manufacturing capacity), and Indicator Capital’s network into that ecosystem is a meaningful asset for hardware-software founders. For Brazilian or LatAm founders building industrial-health crossover plays, the firm is a credible early partner. For pure software founders without hardware components or industrial adjacencies, the strategic logic is thinner.

The right entry path is a warm intro from a portfolio founder, a regional VC with industrial IoT experience, or a corporate development contact at one of the Brazilian industrial conglomerates. The firm reads partner-led decks and responds to clear hardware-software theses with credible technical depth. The pitch should lead with the technical architecture, the industrial or health enterprise wedge, evidence of early customer traction, and a credible follow-on plan.

Caveats. Hardware-software businesses have different unit economics, capital intensity, and timelines than pure SaaS; founders should be transparent about those realities. The firm’s healthcare-specific portfolio depth is not as concentrated as that of pure-play health funds; reference calls with health-sector founders are advisable. The check size is moderate; for founders raising larger seeds, Indicator should be a participant alongside a real lead. For Brazilian hardware-software founders building at the industrial-health intersection, Indicator Capital is a credible specialist partner; for pure software founders, generalist VCs are a better fit.